About
Chris Schaumburg, Ph.D., M.B.A., is a biotech executive and immunologist focused on business development, corporate affairs, and precision medicine. As of the most recent public Mirador Therapeutics leadership page, he serves as SVP, Corporate Affairs, after earlier roles at Prometheus Biosciences, Urovant Sciences, and Allergan. He also serves on the Scientific Advisory Board of Immunis Biomedical and has previously been publicly associated with the consumer health beverage brand Purps.
Areas of interest
biotechimmunologyinflammationautoimmune diseaseprecision medicinedrug discoveryclinical developmentconsumer healthlongevity